HbA1c作为糖尿病的诊断测试——证据回顾

Q1 Biochemistry, Genetics and Molecular Biology

Clinical Biochemist Reviews Pub Date : 2013-08-01

Chris Florkowski

{"title":"HbA1c作为糖尿病的诊断测试——证据回顾","authors":"Chris Florkowski","doi":"","DOIUrl":null,"url":null,"abstract":"The evidence base in support of HbA1c as a diagnostic test for diabetes mellitus is focused on predicting a clinical outcome, considered to be the pinnacle of the Stockholm Hierarchy applied to reference intervals and clinical decision limits. In the case of diabetes, the major outcome of interest is the long term microvascular complications for which a large body of data has been accumulated, leading to the endorsement of HbA1c for diagnosis in many countries worldwide, with some variations in cut-offs and testing strategies. ","PeriodicalId":34924,"journal":{"name":"Clinical Biochemist Reviews","volume":"34 2","pages":"75-83"},"PeriodicalIF":0.0000,"publicationDate":"2013-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799221/pdf/cbr-34-75.pdf","citationCount":"0","resultStr":"{\"title\":\"HbA1c as a Diagnostic Test for Diabetes Mellitus - Reviewing the Evidence.\",\"authors\":\"Chris Florkowski\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The evidence base in support of HbA1c as a diagnostic test for diabetes mellitus is focused on predicting a clinical outcome, considered to be the pinnacle of the Stockholm Hierarchy applied to reference intervals and clinical decision limits. In the case of diabetes, the major outcome of interest is the long term microvascular complications for which a large body of data has been accumulated, leading to the endorsement of HbA1c for diagnosis in many countries worldwide, with some variations in cut-offs and testing strategies. \",\"PeriodicalId\":34924,\"journal\":{\"name\":\"Clinical Biochemist Reviews\",\"volume\":\"34 2\",\"pages\":\"75-83\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799221/pdf/cbr-34-75.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Biochemist Reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Biochemistry, Genetics and Molecular Biology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Biochemist Reviews","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}

引用次数: 0

摘要

支持HbA1c作为糖尿病诊断测试的证据基础主要集中在预测临床结果上，被认为是斯德哥尔摩等级的顶峰，适用于参考区间和临床决策限制。在糖尿病的情况下，主要关注的结果是长期微血管并发症，这方面已经积累了大量数据，导致全球许多国家认可HbA1c作为诊断标准，但在临界值和检测策略方面存在一些差异。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

HbA1c as a Diagnostic Test for Diabetes Mellitus - Reviewing the Evidence.

The evidence base in support of HbA1c as a diagnostic test for diabetes mellitus is focused on predicting a clinical outcome, considered to be the pinnacle of the Stockholm Hierarchy applied to reference intervals and clinical decision limits. In the case of diabetes, the major outcome of interest is the long term microvascular complications for which a large body of data has been accumulated, leading to the endorsement of HbA1c for diagnosis in many countries worldwide, with some variations in cut-offs and testing strategies.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinical Biochemist Reviews Biochemistry, Genetics and Molecular Biology-Clinical Biochemistry

自引率

0.00%

发文量